Drugs / EN41-FPA2
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT01509144 Comparator | Jan 2012 → Jun 2013 | HIV infectious disease | PX'Therapeutics | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | EN41-FPA2 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01509144 ↗ |
| Modality | Vaccine | “EN41-FPA2 HIV vaccine” NCT01509144 ↗ |
| Route | Intranasal | “nasal route” NCT01509144 ↗ |